Skip to main content

Change location

You are currently on the USA (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (English)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Careers
  • Media and News
  • Get in touch
  • Product Security
  • Sign up
    • USA (English)
  • We are Bracco Diagnostics
    We are Bracco

    Welcome to a World of contrasts

    • Bracco at a glance
    • Past, present, future
    • Our Foundation
    • Our business
  • Our portfolio

    To order products go to myorders.bracco.com

    • X-ray & CT
      • Products

        • ISOVUE and Imaging Bulk Package
        • GASTROGRAFIN
        • READI-CAT 2 SMOOTHIE
        • READI-CAT 2
        • TAGITOL V
      • Fluoroscopy

        • VARIBAR
        • CYSTOGRAFIN
        • CYSTOGRAFIN-DILUTE
        • E-Z-DISK
        • E-Z-GAS II
        • E-Z-HD
        • E-Z-PAQUE
        • ENTERO VU
        • GASTROGRAFIN
        • Liquid E-Z-PAQUE
      • Myelography

        • ISOVUE-M 200/300
      • Medical devices

        • Empower CTA+
        • NEXO
        • PROTOCO2L TOUCH
    • MRI
      • Contrast agents

        • VUEWAY
        • MultiHance
        • ProHance
      • Medical Devices

        • Max 3
        • EmpowerMR
      • AI

        • AiMIFY
      • Other

        • CitraClear™
    • Ultrasound
      • Contrast agents

        • LUMASON
    • Nuclear medicine
      • Products

        • CardioGen-82
        • HeartSee
        • Kinevac
        • Choletec
    • Cardiology
      • Contrast agents

        • CardioGen-82
        • Lumason
        • ISOVUE
        • ACIST CVi
        • Heartsee
    • Digital solutions
    • Reimbursement
    • Oncology
  • Bracco innovation—the driving force behind everything we do, building upon our unique culture of research and discovery.
    Innovation

    A deep dive into our R&D progress

    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage
  • Knowledge header
    Knowledge

    Current activities and future opportunities

    • Educational programs
    • Partnerships and sponsorships
    • Events
  • bracco sustainability report
    Sustainability

    Our game plan and goals for a better world

    • Our sustainability pillars
    • Governance and transparency
    • Sustainability report
  • Our Stories
Article
Diana Bracco on People-First Sustainable Development Learn about Diana Bracco’s vision for sustainability in healthcare and her commitment to people-centric innovation across the industry.
Fulvio Renoldi Bracco Spin Torviscosa
Article
Brande Plotnick’s Story: Breast Cancer Prevention Discover Brande Plotnick’s inspiring breast cancer prevention journey, highlighting early detection and lifestyle awareness.
Brande Plotnick: Full Speed Ahead
Article
Applied Radiology Honors Emerging Leaders Meet the innovators recognized by Applied Radiology’s “Leaders on the Horizon” program and how they’re shaping the future of medical imaging.
leaders on the horizon
Article
Bracco and Ulrich Medical Announce Strategic Partnership Bracco partners with Ulrich Medical to deliver advanced injector technologies for enhanced workflow efficiency in diagnostic imaging.
EUSOMII interview
Article
Vueway®(gadopiclenol) Authorized in the EU for Advanced MRI Imaging Bracco announces marketing authorization in European Union of Vueway® (gadopiclenol), a new macrocyclic gadolinium-based contrast agent for CE-MRI.
Bracco Joined the United Nations Global Compact
Article
New Bracco and Samsung Medison Partnership Agreement Bracco Imaging partners with Samsung Medison to advance diagnostic imaging technologies and improve clinical accuracy for patient care globally.
Samsung Medison (CEO, Mr. Yongkwan Kim) and Bracco Imaging (CEO, Dr. Fulvio Renoldi Bracco)
Page
Sustainability-stage
No image available
Article
Bracco Group Forms Bracco Japan Learn about Bracco Group’s strategic creation of Bracco Japan, expanding its imaging and diagnostic expertise into the Japanese healthcare market.
Bracco Japan
Article
Bracco Diagnostics Inc. Branded Max 3™ received FDA 510(k) clearance Bracco Diagnostics Inc. Branded Max 3TM, a Rapid Exchange and Syringeless Injector, received FDA 510(k) clearance adding evolving innovation in Magnetic Resonance Imaging (MRI) and its product portfolio.
Max 3, a Rapid Exchange and Syringeless Injector
Article
New Bracco Suisse and Verasonics Strategic Partnership Bracco Suisse partners with Verasonics to advance ultrasound imaging technology and enhance diagnostic capabilities for clinicians worldwide.
Verasonics logo
  • Load More

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our portfolio
  • Innovation
  • Knowledge
  • Sustainability
  • Our stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • for Bracco VPN users

Bracco Copyright © 2025 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182